BTC Health

BTC Health ROE

The Return on Equity (ROE) of BTC Health (BTC.AX) as of Oct 12, 2026 is 0.31 %. In the previous year, Return on Equity (ROE) was 43.48 % — a change of -99.29% (lower).

ROE

0.31 %

YoY

-99.29%

Last updated:

In 2026, BTC Health's return on equity (ROE) was 0.31 %, a -99.29% increase from the 43.48 % ROE in the previous year.

The BTC Health ROE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROE
Date
ROE
Jan 1, 2019
-4.81 AUD
Jan 1, 2020
-2.52 AUD
Jan 1, 2021
-3.62 AUD
Jan 1, 2022
-4.48 AUD
Jan 1, 2023
-365.76 AUD
Jan 1, 2024
21.34 AUD
Jan 1, 2025
43.48 AUD
Jan 1, 2026
0.31 AUD
The BTC Health ROE history
YEARROEYoY
0.31 %-99.29%
43.48 %+103.80%
21.34 %-105.83%
-365.76 %+8,067.45%
-4.48 %+23.81%
-3.62 %+43.52%
-2.52 %-47.55%
-4.81 %-90.27%
-49.38 %+280.36%
-12.98 %-62.90%
-34.99 %-28.50%
-48.94 %-67.20%
-149.22 %—
Access this data via the Eulerpool API
Get Free API Key

BTC Health Stock analysis

What does BTC Health do? BTC Health Ltd is a British company specializing in the production and distribution of medical devices and pharmaceuticals. The company was founded in 2005 and is headquartered in London. Business model BTC Health Ltd's business model is based on the manufacturing and distribution of medical devices and pharmaceuticals that meet the highest quality standards. The company works closely with medical professionals and research institutions to develop innovative products that meet the needs of patients and healthcare providers. Divisions BTC Health Ltd is divided into several divisions, each offering different products and services. The main divisions are: - Medical Technology - Diagnostics - Pharmaceuticals Medical Technology The Medical Technology division manufactures a wide range of medical devices, including ventilators, infusion pumps, defibrillators, and patient monitors. These devices are used in hospitals, clinics, and care facilities to accurately monitor and treat patients. Diagnostics The Diagnostics division offers a variety of laboratory and diagnostic products, including blood glucose monitors, test strips, immunassays, and ELISA kits. These products are used for the rapid and reliable identification of diseases, enabling effective treatment. Pharmaceuticals The Pharmaceuticals division specializes in the production and distribution of innovative pharmaceuticals specifically developed for the treatment of rare diseases and serious illnesses. Products include cancer medications, antibody therapeutics, and treatments for rare metabolic disorders. Products BTC Health Ltd offers a wide range of medical devices and pharmaceuticals that meet the highest quality standards. Some of the key products include: - VasoPress (medication for the treatment of low blood pressure) - Episcan (ultrasound device for early detection of breast cancer) - Novotest (test for diagnosing kidney dysfunction) - Bongo (infusion pump for medication dosing) - Nonin Xpod (patient monitor for monitoring vital signs) Conclusion BTC Health Ltd is a leading company in the production and distribution of medical devices and pharmaceuticals. The company is committed to developing innovative products that meet the needs of patients and healthcare providers. With a wide range of products in various divisions, BTC Health Ltd is well positioned to be an important partner in the healthcare industry in the future. BTC Health is one of the most popular companies on Eulerpool.

ROE Details

Decoding BTC Health's Return on Equity (ROE)

BTC Health's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing BTC Health's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

BTC Health's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in BTC Health’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about BTC Health stock

Return on Equity (ROE) of BTC Health is 0.31 % in 2026.

Return on Equity (ROE) of BTC Health changed from 43.48 % to 0.31 %, representing a -99.29% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) BTC Health since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s BTC Health with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API
Get Free API Key

Profitability — BTC Health

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — BTC Health